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ABSTRACT
Objective: This study investigated effects of heat treatment on the crystallinity and phase composition of hydroxyapatites (HAs) of different heat 
treatment.
Methods: HA powder was synthesized by the chemical precipitation method based on the reaction between the phosphorous acid and calcium 
hydroxide. Synthesized HA was divided into three groups for which each group was then given heat treatment at 100°C, 900°C, or 1300ºC. Phase 
identification, analyses and the crystallinity of the synthesized HAs were determined using the X-ray diffraction coupled with the Rietveld refinement.
Results: The synthesized HAs with each heat treatment were identified as HA phase containing hexagonal structure. Those treated at 100°C or 900°C 
revealed with crystallinity of 48% and 68%, respectively, with no additional phase; whereas, those treated at 1300°C produced a crystallinity of 72% 
and contained dicalcium and tricalcium phosphates.
Conclusion: The synthesized HAs treated at 100°C, 900°C, or 1300°C were HA phase with hexagonal structure. The variable crystallinity of the 
synthesized HAs yielded from different heat treatment temperature correspondingly determines different phase composition.
Keywords: Amorphous, Crystallinity, Heat treatment, Hydroxyapatite, Secondary phase.
INTRODUCTION
One may suffer from bone destruction due to tooth extraction or 
physiological alveolar bone resorption in elderly patients for which these 
conditions need to be treated. For bone regeneration treatment, tissue 
engineering is considered as a promising alternative approach [1-3]. 
In this approach, tissue engineering has particularly been using an 
artificial device (scaffold), functions as a template to support and guide 
the growth of cells through the porous structures, implanted in bone 
defects in a patient’s body [3,4]. Scaffold materials, therefore, have to 
mimic a normal calcified tissue of human bone, the biological apatite. 
The most similar calcium phosphate-based bioceramics to biological 
apatite has been hydroxyapatite (HA), having a molecular formula of 
Ca10(PO4)6(OH)2, with a molar ratio of Ca/P 1.67 and showing the most 
similar crystallography [5-7].
HAs with high heat treatment have been studied. High heat treatment 
led to grain growth and densification which increased their crystallinity, 
to obtain high mechanical strength, suitable for orthopedics 
applications. For example, synthesized HA with a heat treatment 
up to 1200°C demonstrated an increase in hardness and fracture 
strength [8]. Further heat treatment of HA up to 1250°C has resulted 
with even superior hardness and fracture toughness [9]. Despite being 
advantageous, limitations remain in the difficulty for a crystalline 
HA. The successful growth of cells cultured in a scaffold requires the 
scaffold being degradable, to be resorbable [3,4].
Efforts to raise degradability of a scaffold have been studied using an 
amorphous HA. Calcium phosphate-based phases are having a molar 
ratio of Ca/P <1.7, such as tricalcium phosphate, have shown to be more 
degradable. Studies showed that biphasic structure of HA and tricalcium 
phosphate (HA/TCP) have drawn considerable attention because they 
are able to show better degradation [3,10,11]. In fact, most studies 
of biphasic HA/TCP scaffold employed commercially available HAs. 
Commercially available HAs possessed the heat treatment estimated to 
be between 900°C and 1300°C [12].
Crystallinity of HA is considered as an important parameter as the 
degradability of a scaffold is strongly dependent on them. Crystalline 
HA is bioinert and less degradable when it is used for scaffolds. On 
the other hand, very low heat treatment of HA may result with an 
amorphous effect; in addition, their degradation in the form of micro-
particle released is feared to cause cellular damages occurring around 
an implanted scaffold. To gain insights into crystalline HA for scaffold 
applications for tissue engineering, it is important to analyze the 
crystallinity and phase composition of a synthesized HA. Therefore, this 
study aims to explore the crystallinity and phase of the composition of 
HA with different heat treatments.
METHODS
Synthesis of HA powders
The reagents used were calcium hydroxide [Ca(OH)2] and 
orthophosphoric acid [H3PO4]. All analytical grade reagents used in this 
work were purchased from Sigma-Aldrich (St. Louis, Missouri, USA). 
Synthesis of HA was conducted using the wet chemical precipitation 
method, following previous studies [9,13-15]. In brief, H3PO4 and 
Ca(OH)2 were as shown in the chemical reaction below:
10Ca(OH)2+6H3PO4Ca10(PO4)6(OH)2+18H2O
The mixing was conducted by addition of H3PO4 powder into Ca(OH)2 
suspension in water in a dropwise manner and a controlled rate for 1 h. 
Vigorous mixing was carried out by continued stirring on a magnetic 
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stirrer (Heidolph MR 3001, Germany) at ±900 rpm and maintained 
for 24 h. At the end of the stirring process, pH of the mixture was 11–
12 and was then adjusted to pH 7. The mixture was aged overnight; 
wet cakes produced from the precipitate were subjected to filtering 
adapted in a Büchner funnel until dry and were repeatedly washed with 
deionized water. After further drying in a furnace, dried cakes at the 
bottom were ground into fine powder and were then divided into three 
groups and each group was given a heat treatment at 100°C, 900°C, or 
1300°C, with a stepwise of 0.5°C/min and maintained for 3 h before 
furnace-cooled down to room temperature. A commercially available 
HA (Sigma-Aldrich, St. Louis, Missouri, USA) was used as a comparison.
X-ray diffraction (XRD) and crystallinity determination
Synthesized HA powder was prepared in molds of 25 mm in inner diameter 
and 2 mm in thickness to produce samples. The samples were mounted in 
and scanned with an XRD (PW-1170, Phillips, Netherland), with Cu-Kα and 
λ=1.5406 Å. Data from the samples were collected in the 2θ range from 
10 to 80° by step counting at 0.02 deg. intervals for 0.6 seconds per data 
point. The XRD coupled with the Rietveld refinement, as implemented 
in the GSAS program, was utilized to obtain the lattice parameter. It was 
also used to measure the crystallinity of each group, which was measured 
from a crystalline to the total area, including the amorphous phase; the 
crystalline area is the sum of the integrated intensities scattered over a 
suitable angular interval by crystalline phase. It was also used to detect 
the existence of secondary phases by comparing the diffraction patterns 
of the synthesized HA with the International Centre for Diffraction Data 
(ICDD; Newtown Square, PA) File Card No. 09-0432 for Ca10(PO4)6(OH)2 
(HA), File Card No. 96-100-1557 for Ca2P2O7 (dicalcium phosphate [DCP]), 
File Card No. 96-900-5866 for Ca3(PO4)2 (tricalcium phosphate), and File 
Card No. 44-1481 for CaO (calcium oxide).
RESULTS
The synthesis of HA obtained from the chemical precipitation method 
used in this study was confirmed by XRD patterns, as was shown in 
Fig. 1.
As in Fig. 1, characteristic peaks of each pattern were attributed 
to the crystallographic planes at (002), (210), (211), (112), (300), 
(202), (310), (222), (213), (004), and (304). All the peaks can be 
matched with the ICDD no. 09-0432 for HA. The XRD pattern 
displayed evident similarities in their characteristic peaks; 
however, there were differences observed from peak broadening 
(Fig. 1). In correspondence with the view, the synthesized HA with 
heat treatment at 100°C were observed with broad peaks. It was 
estimated that at 100°C, the synthesized HA was contributed by less 
grain growth, less perfect crystal in the range of Angstroms showing 
microcrystalline particles of a large fraction of a poorly crystallized 
material. Further increasing to 900°C, narrow peaks were observed 
with enhanced resolution and they became sharper at 1300°C. Here, 
the synthesized HA were likely to result with large particles. Further 
identification of HA using the Rietveld refinement showed the lattice 
parameters and the crystallinity values, as were shown in Table 1.
As we can see in Table 1, the lattice parameter of each synthesized HA 
phase with different heat treatment. The parameters = 90o and 120o 
confirmed the hexagonal crystal structure with the space group of 
P63/m (ICDD File Care No. 09-0432).
The parameters displayed increasing values, presenting the HAs were 
given increased heat treated. However, they displayed small variation 
Fig. 1: X-ray diffraction patterns from the synthesized hydroxyapatite (HA) treated at 100°C, 900°C, or 1300°C and the commercially 
available HA
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compared to that obtained from the commercially available HA. These 
results were also accordance with those obtained from nano-sized 
HA particles [16,17]. With respect to the crystallinity, the synthesized 
HA samples with the heat treatment at 100°C have revealed with a 
value of 48%. Increasing the heat treatment to 900°C resulted with 
the crystallinity of 65%, which was raised by about 17% compared to 
that with 100°C. Further increasing the heat treatment to 1300°C has 
further elevated the crystallinity to nominally 72%, which was 7% 
higher than that with 900°C. When the commercially available HA with a 
crystallinity of 86% was considered, the crystallinity of the synthesized 
HA samples was known to be lower. The refinement allowed ensure 
better reliability and identification of the additional phases, as were 
seen in Fig. 2 and summarized in Table 2.
The XRD pattern in Fig. 2a showed that the synthesized HA with heat 
treatment at 100°C was accompanied with peaks attributed to planes 
at (111), (200), and (220). This was consistent with the ICDD Card File 
No. 44-1481 for CaO. As was seen in Table 2, the mass fraction of the CaO 
phase, however, was as low as 0.74%, which may not be a significant amount.
In Fig. 2b, the XRD pattern showed that the synthesized HA samples 
with heat treatment at 900°C (Table 2) came with no additional peak. 
Thus, they contained 100% HA phase. Regarding the commercially 
available HA (Fig. 2d), no other peak corresponding to any secondary 
phase was also seen, meaning that it contained 100% HA phase. The 
results showed that the synthesized HA-treated at 900°C and the 
commercially available were in accordance.
Heated at 1300°C (Fig. 2c), the synthesized HA samples demonstrated 
planes at (020), (023), (015), (009), (205), and (025) that can be 
indexed with the ICDD Card File No. 96-100-1557 for DCP. The planes 
at (022), (110), (202), and (008) agreed with ICDD Card File No. 96-
900-5866 for tricalcium phosphate.
We found that the synthesized HA with heat treatment at 1300°C has 
produced main HA, DCP and tricalcium phosphate phases (Table 2). 
The mass fractions were noticed to be nominally 56.07%, 33.23%, 
and 10.70%, respectively. Although the apparent secondary phase was 
totally 43.93%, which was nearly similar to the main HA phase, the 
crystallinity noted to be 72% was still higher than that heated at 900°C.
DISCUSSION
The XRD patterns occurred from each synthesized HA agreed well with 
those published in other literature. The XRD patterns were similar with 
those prepared using a similar method, either with similar reagents or 
different chemicals employed as were used in this study [9,13-15,18].
The analogies between the XRD patterns obtained from the synthesized 
HA and those from the commercially available HA showed that both 
resemble each other. These typical of HA was similar to that from a 
bovine bone as reported earlier [19,20].
The XRD pattern of the extracted HA from the bovine bone with heat 
treatment at 100°C, as previously described, was similar to that of the 
synthesized HA with the same heat treatment in this study.
The occurrence of CaO phase may be due to phosphorous containing 
precursors which are potentially volatile; hence, calcium-containing 
precursor molecules have difficulty to be incorporated into the complex. 
The synthesized HA samples with relatively low heat treatment at 
100°C can be considered as poorly crystallized material (Table 1). As 
observed in Fig. 1, the change of the peaks from narrow at 900°C to 
broad at 100°C indicated that the change of the synthesized HA samples 
was from crystalline to amorphous.
The findings from this study were accordance to previous studies on 
applying high heat treatment to synthesized HAs that occurred with 
secondary phases, as presented by additional reflections on their XRD 
patterns. Ramesh et al. demonstrated that the formation of tricalcium 
phosphate and DCP phases when HA was heated at 1300°C was 
unavoidable [9]. A report mentioned that HA with lower heat treatment 
at 1200°C has also occurred with tricalcium phosphate phase [21]. 
With respect to the HA phase diagram, HA decomposed at around 
1180°C [22]. It was also reported that the transformation of HA into 
tricalcium phosphate at a lower heat treatment of 1100°C [23].
Biodegradation of a scaffold occurs from the time of implantation 
in vivo to the completion of bone regeneration [24,25]. Controlling 
the biodegradation rate of any scaffold to match the bone tissues 
regeneration rate requires a balance between degradability and on 
the other hand a sufficient mechanical integrity. To obtain scaffolds 
with these requirements, one of the greatest challenges in tissue 
engineering should address a well-defined HA scaffold and observe the 
biodegradability and worth mentioning the mechanical integrity.
Tricalcium phosphate and DCP phases, having a molar ratio of Ca/P 1.5 
and 1.43, respectively, have been the most used calcium phosphate to 
construct biphasic HA-based scaffolds [10]. In this study, the presence 
of tricalcium phosphate and DCP phases in the synthesized HA-
treated at 1300°C was actually an advantage for the intention to raise 
biodegradability of the scaffold. However, HA-treated at 1300°C showed 
relatively high crystallinity. When in an implantation, the residual 
crystalline HA of the scaffold may escape from biodegradation. In this 
Table 1: Lattice parameter and mass fraction of the synthesized HA-treated at 100°C, 900°C, or 1300°C and the commercially available 
HA
Heat treatment of HA (°C) Lattice parameter Crystallinity (%)
α=β ≠ γ (°) a=b ≠ c(Å)
γ (o) a=b(Å) γ (o) c(Å)
Synthesized
100 90 120 9.404 6.902 48
900 90 120 9.406 6.977 65
1300 90 120 9.407 6.999 72
Commercially available 90 120 6.999 86
HA: Hydroxyapatite
Table 2: Phases and mass fractions of the synthesized 















Commercially available HA 100.0
HA: Hydroxyapatite, DCP: Dicalcium phosphate, TCP: Tricalcium phosphate
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case, HA-treated between 100°C and 900°C, such as obtained from this 
study, may be admired to obtain amorphous HA.
Furthermore, to obtain higher biodegradation of HA-based scaffolds, 
HA has been composited with biopolymer. In the past decade, 
polysaccharides, such as alginates and/or chitosan have been used in 
biomedical purposes [26,27]. Future studies, therefore, may develop 
scaffolds of HA combined with chitosan and/or alginate for tissue 
engineering.
CONCLUSION
Synthesize HAs produced by the wet chemical precipitation and heat 
treated at 100°C, 900°C or 1300°C were identified as HA phase and 
shown to consist of the hexagonal crystal structure with the space 
group of P63/m. HAs treated at 1300°C was considered crystalline and 
contained dicalcium and tricalcium phosphate, whereas, those treated 
at 100°C or 900°C presented no significant amount of additional phase 
and was considered amorphous.
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